|
Zenarestat
|
折那司他
|
112733-06-9
|
|
Boc-D-Asp-OBzl
|
N-叔丁氧羰基-D-天冬氨酸 1-芐酯
|
92828-64-3
|
|
N-(tert-Butoxycarbonyl)-S-butylhomocysteine
|
N-(叔丁氧基羰基)-S-丁基高半胱氨酸
|
1396969-20-2
|
|
Alectinib Hydrochloride
|
艾樂替尼鹽酸鹽
|
1256589-74-8
|
|
(S)-2-(tert-butoxycarbonylamino)-3-(4-carbamoyl-2,6-dimethylphenyl)propanoic acid
|
4-(氨基羰基)-N-[(1,1-二甲基乙氧基)羰基]-2,6-二甲基-L-苯丙氨酸
|
623950-02-7
|
|
Afuresertib hydrochloride
|
N-((S)-1-氨基-3-(3-氟苯基)丙-2-基)-5-氯-4-(4-氯-1-甲基-1H-吡唑-5-基)噻吩-2-甲酰胺鹽酸鹽
|
1047645-82-8
|
|
(S)-Methyl 2-((S)-2-((S)-2-amino-4-phenylbutanamido)-4-methylpentanamido)-3-phenylpropanoate 2,2,2-trifluoroacetate
|
(ALPHAS)-ALPHA-氨基苯丁酰基-L-亮氨?；?L-苯丙氨酸甲酯單(三氟乙酸鹽)
|
868539-99-5
|
|
Fmoc-1-methyl-L-histidine
|
N-[芴甲氧羰基]-1-甲基-L-組氨酸
|
202920-22-7
|
|
Fmoc-Ala-OH
|
N-芴甲氧羰基-L-丙氨酸
|
35661-39-3
|
|
CNQX
|
6-氰基-7-硝基喹喔啉-2,3-二酮
|
115066-14-3
|
|
AMPK activator 4
|
化合物 AMPK ACTIVATOR 4
|
2493239-46-4
|
|
Glycyltyrosine dihydrate
|
甘氨酰酪氨酸
|
39630-46-1
|
|
AKT-IN-6
|
INCB-047775
|
1430056-54-4
|
|
Belizatinib
|
CS-2493
|
1357920-84-3
|
|
Fmoc-Phe(4-I)-OH
|
Fmoc-L-4-碘苯丙氨酸
|
82565-68-2
|
|
JH-VIII-157-02
|
化合物 T15612
|
1639422-97-1
|
|
GSK2110183 analog 1 hydrochloride
|
2070009-64-0
|
2070009-64-0
|
|
Iruplinalkib
|
伊魯阿克
|
1854943-32-0
|
|
PI3K/Akt/mTOR-IN-2
|
化合物 PI3K/AKT/MTOR-IN-2
|
2757804-89-8
|
|
Fmoc-Asp(OtBu)-OH
|
Fmoc-L-天冬氨酸 beta-叔丁酯
|
71989-14-5
|
|
Tolrestat
|
托雷斯萘
|
82964-04-3
|
|
AT13148
|
AT13148
|
1056901-62-2
|
|
Afuresertib
|
GSK-2110183C
|
1047644-62-1
|
|
Ipatasertib dihydrochloride
|
(2S)-2-(4-氯苯基)-1-[4-[(5R,7R)-6,7-二氫-7-羥基-5-甲基-5H-環(huán)戊并嘧啶-4-基]-1-哌嗪基]-3-[(1-甲基乙基)氨基]-1-丙酮二鹽酸鹽
|
1396257-94-5
|
|
HTH-01-015
|
HTH-01-015
|
1613724-42-7
|
|
A-674563 hydrochloride
|
A-674563 (hydrochloride)
|
2070009-66-2
|
|
Boc-D-Leucine monohydrate
|
N-叔丁氧羰基-D-亮氨酸
|
200937-17-3
|
|
MK8722
|
MK-8722
|
1394371-71-1
|
|
COH-SR4
|
COH-SR4
(Mitochondria uncoupler SR4)
|
73439-19-7
|
|
Vevorisertib trihydrochloride
|
化合物VEVORISERTIB TRIHYDROCHLORIDE
|
1416775-08-0
|
|
7-Methoxyisoflavone
|
7-甲氧基異黃酮
|
1621-56-3
|
|
(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(o-tolyl)propanoic acid
|
FMOC-L-2-甲基苯丙氨酸
|
211637-75-1
|
|
Fmoc-Lys(Mtt)-OH
|
Fmoc-N'-甲基三苯甲基-L-賴氨酸
|
167393-62-6
|
|
Lidorestat
|
利多司他
|
245116-90-9
|
|
ALK inhibitor 1
|
2-[[5-溴-2-[[2-甲氧基-4-(4-甲基-1-哌嗪基)苯基]氨基]-4-嘧啶基]氨基]-N-甲基苯磺酰胺
|
761436-81-1
|
|
AZD-3463
|
AZD3463
|
1356962-20-3
|
|
CNQX disodium salt
|
6-CYANO-7-NITROQUINOXALINE-2;3-DIONE DISODIUM
|
479347-85-8
|
|
Caficrestat
|
AT-001
|
1355612-71-3
|
|
PF-06409577
|
PF-06409577
|
1467057-23-3
|
|
MS4077
|
MS4077
|
2230077-10-6
|
|
(S)-2-amino-3-(4-benzoylphenyl)propanoic acid
|
4-苯甲?；?L-苯基丙氨酸
|
104504-45-2
|
|
UNC5293
|
化合物 T9134
|
2226789-82-6
|
|
Zopolrestat
|
唑泊司他
|
110703-94-1
|
|
O-(tert-Butyl)-N-Fmoc-L-allothreonine
|
紅曲玉紅胺
|
201481-37-0
|
|
Pep2m, myristoylated
|
Pep2m, myristoylated
|
1423381-07-0
|
|
Fmoc-Trp(Me)-OH
|
FMOC-TRP(1-ME)-OH
|
1334509-86-2
|
|
Uprosertib
|
UPROSERTIB
|
1047634-65-0
|
|
Brigatinib
|
布格替尼
|
1197953-54-0
|
|
Boc-Ala-NMe(OMe)
|
N-(叔丁氧基羰基)-L-丙氨酸-N′-甲氧基-N′-甲酰胺
|
87694-49-3
|
|
O-304
|
化合物O-304
|
1261289-04-6
|
|
EB-3D
|
EB-3D
|
1839150-63-8
|
|
MS4078
|
MS4078
|
2229036-62-6
|
|
ALM301
|
化合物 ALM301
|
1313439-71-2
|
|
PI3K/Akt/CREB activator 1
|
化合物 PI3K/AKT/CREB ACTIVATOR 1
|
2708177-73-3
|
|
Boc-L-Tyrosine methyl ester
|
Boc-L-酪氨酸甲酯
|
4326-36-7
|
|
A-674563
|
A-674563
|
552325-73-2
|
|
cis-Fmoc-Pro(4-N3)-OH
|
(2S,4S)-4-疊氮基-1,2-吡咯烷二甲酸 1-(9H-芴-9-基甲基)酯
|
263847-08-1
|
|
Ipatasertib
|
帕他色替
|
1001264-89-6
|
|
NBQX
|
二羥基喹酮
|
118876-58-7
|
|
Fmoc-Lys(Alloc)-OH
|
N-[(9H-芴-9-甲氧基)羰基]-N'-[(2-丙烯氧基)羰基]-L-賴氨酸
|
146982-27-6
|
|
R-268712
|
2025
|
879487-87-3
|
|
ALK kinase inhibitor-1
|
(7-(5-fluoro-2-methoxyphenyl)-2-((2-isopropoxy-4-(4-methylpiperazin-1-yl)phenyl)amino)thieno[3,2-d]pyrimidin-6-yl)methanol
|
1462949-64-9
|
|
Fmoc-D-Phe(4-F)-OH
|
FMOC-D-4-氟苯丙氨酸
|
177966-64-2
|
|
ALDH1A1-IN-2
|
NCT-507
|
2231081-18-6
|
|
Sincalide ammonium
|
SINCALIDE AMMONIUM (CHOLECYSTOKININ OCTAPEPTIDE AMMONIUM)
|
70706-98-8
|
|
Fmoc-Asp-OtBu
|
芴甲氧羰基-L-天冬氨酸-1-叔丁酯
|
129460-09-9
|
|
ZX-29
|
ZX-29
|
2254805-62-2
|
|
(E)-Akt inhibitor-IV
|
CS-1992
|
959841-49-7
|
|
Fidarestat
|
非達(dá)司他
|
136087-85-9
|
|
XST-14
|
化合物 XST-14
|
2607143-50-8
|
|
Akt1/Akt2-IN-1
|
3-苯基-2-[4-[[4-[5-(2-吡啶)-1H-1,2,4-三唑-3-基]-1-哌啶]甲基]苯基]-1,6-萘啶-5(6H)-酮
|
893422-47-4
|
|
ASP3026
|
ASP3026
|
1097917-15-1
|
|
N-((Benzyloxy)carbonyl)-O-(tert-butyl)-L-threonine
|
-叔丁基-L-蘇氨 Z-氨基酸
|
16966-09-9
|
|
Miransertib
|
ARQ-092
|
1313881-70-7
|
|
N-Formyl-L-leucine
|
N-甲?；?L-亮氨酸
|
6113-61-7
|
|
Imirestat
|
咪瑞司他
|
89391-50-4
|
|
N6-Diazo-L-Fmoc-lysine
|
(2S)-N-FMOC-6-疊氮基己酸
|
159610-89-6
|
|
NCT-501
|
CS-2069
|
1802088-50-1
|
|
NCT-506
|
NCT-506
|
2231098-99-8
|
|
Fmoc-Arg(Pbf)-OH
|
Fmoc-Pbf-精氨酸
|
154445-77-9
|
|
IM156
|
IM156
|
1422365-94-3
|
|
Ampalex
|
安帕來斯
|
154235-83-3
|
|
Sorbinil
|
索比尼爾
|
68367-52-2
|
|
H-Phg(4-Cl)-OH
|
(S)-4-氯苯甘氨酸
|
67336-19-0
|
|
Fmoc-Phe(3,4-DiF)-OH
|
FMOC-L-3,4-二氟苯丙氨酸
|
198560-43-9
|
|
MKC-1
|
化合物MKC-1
|
125313-92-0
|
|
HG-14-10-04
|
CS-1175
|
1356962-34-9
|
|
K-80003
|
1292821-90-9
|
1292821-90-9
|
|
Repotrectinib
|
洛普替尼
|
1802220-02-5
|
|
Fmoc-Gly(allyl)-OH
|
Fmoc-L-烯丙基甘氨酸
|
146549-21-5
|
|
Crosstide
|
模擬肽CROSSTIDE
|
171783-05-4
|
|
Fmoc-L-Lys(Dde)-OH
|
N-FMOC-N'-[1-(4,4-二甲基-2,6-二氧代環(huán)己亞基)乙基]-L-賴氨酸
|
150629-67-7
|
|
N-Fmoc-O-benzyl-L-tyrosine
|
Fmoc-O-芐基-L-酪氨酸
|
71989-40-7
|
|
(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(furan-2-yl)propanoic acid
|
FMOC-D-3-(2-呋喃基)丙氨酸
|
220497-85-8
|
|
COG 133
|
COG-133; COG133
|
514200-66-9
|
|
2-((3-Fluoro-4-(methylcarbamoyl)phenyl)amino)-2-methylpropanoic acid
|
N-[3-氟-4-[(甲基氨基)羰基]苯基]-2-甲基丙氨酸
|
1289942-66-0
|
|
(S)-methyl 2-((S)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamido)-3-phenylpropanoate
|
(ALPHAS)-ALPHA-[[2-(4-嗎啉基)乙?；鵠氨基]苯丁?；?L-亮氨?；?L-苯丙氨酸甲酯
|
1140908-89-9
|
|
Entrectinib
|
恩曲替尼
|
1108743-60-7
|
|
tert-Butyl 2-aminoacetate
|
甘氨酸叔丁酯
|
6456-74-2
|
|
AT-007
|
AT-007
|
2170729-29-8
|